Navigation Links
The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance

Conference Call and Webcast Scheduled for October 31, 2008 at 11:30 am ET

MISSION VIEJO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, today reported record results for the third quarter of fiscal year 2008.

Third Quarter Highlights Include:

-- Total revenue was a record $116.3 million, up 11.8% over the third

quarter of 2007; and organic revenue was $113.5 million, up 9.8% over

the prior year;

-- Skilled revenue for the quarter increased 24.6% over the prior year to

$51.4 million, as skilled mix improved 460 basis points to 46.3%;

-- EBITDA improved 45.6% in the quarter to $14.2 million, compared to

$9.7 million in 2007;

-- Consolidated net income for the quarter was a record $6.8 million,

compared to $4.5 million the year before, an overall improvement of

52.2%; and

-- The Company had $56.4 million in cash at quarter end, which included

$35.6 million in year-to-date cash flow from operations, a 224.0%

increase over cash flow from operations for the first nine months of

2007 of $11.0 million.

Operating Results

Commenting on the results, Ensign President and Chief Executive Officer Christopher Christensen said, "Despite the economic downturn, we are pleased to report that we have quickly adjusted to achieve the highest revenue and earnings in the third quarter we've ever posted."

He noted that the record third quarter performance builds on record first and second quarters, adding, "We believe that these results graphically reconfirm the fundamental strength in our basic business model. As our outstanding facility leaders and their teams continue market-by-market to improve clinical quality, serve more skilled residents, adjust quickly to changes on the ground and lead previously-underperforming facilities to higher levels, Ensign continues to perform in spite of economic conditions."

Chief Financial Officer Alan Norman reported that revenue was also impacted by the recent California budget delay. "Because of the late budget California, which accounts for about half of our operational beds, has not yet finalized its 2009 Medi-Cal rate increase which should have gone into effect August 1, and so no increase was booked during the period in our California facilities." He noted that if the final rate resulted only in a 2.0% increase, the assumption used to develop management's previously-issued guidance, total revenue would have climbed to $116.7 million, additional an additional $0.01 in earnings per fully diluted share for the quarter. "We expect the rate to be finalized soon, and we will pick up any retroactive reimbursement increase in the 4th quarter," he added.

Christensen also discussed Ensign's industry-low debt ratio and the strength in its balance sheet. "We have been steadily building this balance sheet to prepare for both difficult economic cycles as well as compelling acquisition opportunities, and we believe that we are seeing the convergence of both of these events now and in the coming months," he said. "We believe we are well-positioned to perform and grow during the current economic downturn."

Year-to-date EBITDAR improved 20.5% to $52.4 million, compared to $43.5 million in the first nine months of 2007. Year-to-date EBITDA improved 32.9% to $41.2 million, compared to $31.0 million in the first nine months of 2007. A discussion of the company's use of these non-GAAP financial measures is set forth below, and a reconciliation of net income to EBITDAR and EBITDA appears in the financial data portion of this release.

Year-to-date consolidated net income was $19.7 million compared to $14.3 million the year before, an overall improvement of 37.4%. Net cash from operations grew by more than 224% year-to-date, to $35.6 million.

Fully diluted net earnings per share was $0.33 for the quarter, compared to $0.21 per share in the prior year taking into account the effects of the November 2007 issuance of 4,000,000 additional shares at Ensign's initial public offering, and to $0.26 per share on a GAAP basis.

More complete information is contained in the Company's 10-Q, which was filed with the SEC today and can be viewed on the Company's website at

2008 Guidance Reaffirmed

Management reaffirmed 2008 annual guidance, which was raised following the second quarter of 2008, projecting consolidated revenue of $463 million to $467 million for 2008, up from the previous range of $454 million to $458 million, and fully diluted net earnings per share for 2008 of $1.30 to $1.35, up from the previous range of $1.27 to $1.32. This guidance is based upon diluted weighted average common shares outstanding of 21,000,000 shares and assumes, among other things, no additional acquisitions or dispositions and a continued stable Medicare and Medicaid reimbursement environment.

Recent Highlights

During the quarter the company licensed, certified and opened the newly-completed 32-bed rehabilitation wing at Park Manor Rehabilitation Center, its outstanding skilled nursing and rehabilitation facility in Walla Walla, Washington. The new $3.2 million addition brings the total number of licensed and operating beds at Park Manor to 109, with 10 new private rooms and 11 new semi-private rooms. The rest of the facility is now being updated and remodeled, and two three-bed wards in the existing building have been reconfigured to more comfortably serve two patients each, for a net gain of 30 new operational beds during the quarter. With the project's completion, eight existing beds which had been listed as non-operational during the construction project are back in service as well.

Ensign won the right to build the additional beds in 2006 after successfully navigating Washington's certificate of need process, including several appeals. Proceeds of Ensign's initial public offering were used to complete the construction.

Other Developments

On October 28, 2008 Ensign subsidiaries acquired the assets of four skilled nursing facilities in Texas and California for an aggregate purchase price of approximately $10.4 million. The four facilities include 426 skilled nursing beds. Ensign operating subsidiaries have been operating the three Texas facilities since 1999 and the California facility since 2001. The operating subsidiaries will continue to operate their facilities under new long-term leases with the acquiring entities. The prior lease agreements did not contain purchase options.

Proceeds of Ensign's recent IPO were used to fund the transactions. Management expects the acquisitions to be immediately accretive to earnings.

With the Texas and California acquisitions the Company operates 62 facilities in six Western states, owns 32 of its facilities and operates the other 30 facilities under long-term lease arrangements, with options to purchase eight of those 30 leased facilities.

Conference Call

A live webcast will be held on Friday, October 31, 2008, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) to discuss Ensign's third quarter fiscal year 2008 financial results. To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors section of the Ensign website at The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. (Pacific Time) on Friday, November 7, 2008.

About Ensign(TM)

The Ensign Group, Inc.'s operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services for both long-term residents and short-stay rehabilitation patients, at 62 facilities located in California, Arizona, Texas, Washington, Utah and Idaho. Each of these facilities is operated by a separate, wholly-owned independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "Company" and "its" assets and activities, as well as the use of the terms "we," "us," "our" and similar verbiage are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management's current expectations, assumptions and beliefs about our business, financial performance, operating results, the industry in which we operate and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding our growth prospects, future operating and financial performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to our business, our industry and our common stock and include: reduced prices and reimbursement rates for our services; our ability to acquire, develop, manage or improve facilities, our ability to manage our increasing borrowing costs as we incur additional indebtedness to fund the acquisition and development of facilities; our ability to access capital on a cost-effective basis to continue to successfully implement our growth strategy; our operating margins and profitability could suffer if we are unable to grow and manage effectively our increasing number of facilities; competition from other companies in the acquisition, development and operation of facilities; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit our business operations, require us to incur significant expenditures or limit our ability to relocate our facilities if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review our periodic filings with the Securities and Exchange Commission, including our Form 10-Q, which was filed today, for a more complete discussion of the risks and other factors that could affect Ensign's business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Revenue $116,328 $104,092 $345,425 $302,339


Cost of services

(exclusive of facility

rent and depreciation

and amortization shown

separately below) 94,297 86,176 278,364 247,177

Facility rent-cost

of services 3,282 4,177 11,229 12,511

General and

administrative expense 4,565 3,995 14,628 11,638

Depreciation and

amortization 2,350 1,818 6,513 5,004

Total expenses 104,494 96,166 310,734 276,330

Income from operations 11,834 7,926 34,691 26,009

Other income (expense):

Interest expense (1,183) (1,288) (3,553) (3,637)

Interest income 239 275 1,094 973

Other expense, net (944) (1,013) (2,459) (2,664)

Income before provision

for income taxes 10,890 6,913 32,232 23,345

Provision for income taxes 4,093 2,447 12,582 9,047

Net income $6,797 $4,466 $19,650 $14,298

Net income per share:

Basic $0.33 $0.32 $0.96 $1.04

Diluted $0.33 $0.26 $0.95 $0.85

Weighted average common

shares outstanding:

Basic 20,525 13,506 20,512 13,463

Diluted 20,777 16,878 20,667 16,887

Condensed Consolidated Balance Sheets

(in thousands)

September 30, December 31,

2008 2007


Cash and cash equivalents $56,407 $51,732

Other current assets 58,187 68,631

Total current assets 114,594 120,363

Property and equipment, net 141,893 124,861

Other assets 26,124 22,165

Total assets $282,611 $267,389

Liabilities and stockholders' equity

Current liabilities:

Current liabilities, excluding current

maturities of long-term debt $52,030 $54,401

Current maturities of long-term debt 1,089 2,993

Total current liabilities 53,119 57,394

Long-term debt-less current maturities 59,735 60,577

Other long-term liabilities 21,101 19,741

Total Stockholders' equity 148,656 129,677

Total liabilities and stockholders' equity $282,611 $267,389

Reconciliation of Net Income to EBITDA and EBITDAR

(in thousands)

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Net income $6,797 $4,466 $19,650 $14,298

Interest expense, net 944 1,013 2,459 2,664

Provision for income taxes 4,039 2,447 12,582 9,047

Depreciation and amortization 2,350 1,818 6,513 5,004

EBITDA 14,184 9,744 41,204 31,013

Facility rent-cost of services 3,282 4,177 11,229 12,511

EBITDAR $17,466 $13,921 $52,433 $43,524

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, and (c) depreciation and amortization. EBITDAR consists of EBITDA before facility rent-cost of services. The Company believes that the presentation of EBITDA and EBITDAR provides important supplemental information to management and investors to evaluate the Company's operating performance. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the Company believes that these non-GAAP measures provide useful information to investors, the manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the Company's Report on Form 10-Q filed today with the SEC. The Form 10-Q is available on the SEC's website at or under the "Financial Information" link of the Investor Relations section of Ensign's website at

SOURCE The Ensign Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Ensign Group, Inc. Acquires Four Skilled Nursing Facilities
2. The Ensign Group Schedules 2008 Third Quarter Earnings Call for Friday, October 31, 2008
3. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
4. The Ensign Group Schedules 2008 Second Quarter Earnings Call for Thursday, August 7, 2008
5. The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th
6. The Ensign Group, Inc. Acquires Utah Skilled Nursing Facility
7. The Ensign Group, Inc. Reports First Quarter 2008 Earnings
8. The Ensign Group Schedules 2008 First Quarter Earnings Call for Thursday, May 8, 2008
9. The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings
10. The Ensign Groups Year-End Conference Call Scheduled for Friday, March 7, 2008
11. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class ... could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major ... showed that small molecule analogs that target the functions of SecA, a central ...
(Date:11/30/2015)... ... , ... Using a combination of two blood sugar tests rather than a ... a new study by researchers at the School of Public Health at Georgia State ... of Blood Glucose Tests ,” published in Frontiers in Public Health, the researchers noted ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology ... UPMC and KingMed Diagnostics researchers. Their review of more than ... with UPMC pathologists resulted in significantly altered treatment plans for more than half ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation for Breast and ... prevention—is joining forces with the award-winning creator and writer of Downton Abbey Julian ... 2015 at the Union League of Philadelphia. , The benefit, titled “An ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i ... years, announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as ... years, FHC was awarded the largest Affordable Care Act grant for Federally Qualified ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015 Booth #4303 – The Imaging ... will exhibit a broader array of products in a new ... of North America in ... meeting will feature X-ray components "At the Heart of Imaging." ... of products from Varian,s Claymount brand, and computer-aided diagnostic software ...
(Date:11/30/2015)... EAST HANOVER, N.J. , Nov. 30, 2015 /PRNewswire/ ... and portfolio at the 57 th American Society ... across leukemias, lymphomas and myelomas as well as supportive ... populations, in addition to personalized cell therapies. The ASH ... Orlando, Florida . Novartis Oncology ...
(Date:11/30/2015)... LONDON and BOSTON , ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> PFE ) to ... to 10 G protein-coupled receptor (GPCR) targets across multiple ... clinical-stage GPCR structure-guided drug discovery and development company and ...
Breaking Medicine Technology: